Clinical Trials
19 trialsADJUPANET
Gustave Roussy, Cancer Campus, Grand Paris
CardioNETPOL
National Institute of Cardiology, Warsaw, Poland
Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
NEUK203-13
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms
First Affiliated Hospital of Zhejiang University
SMILE
GCS Ramsay Santé pour l'Enseignement et la Recherche
ETP-NET
Hospices Civils de Lyon
Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
Xijing Hospital
Endoscopic Resection for Small Rectal Neuroendocrine Tumors
Guangdong Provincial People's Hospital
Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors
Beijing Chest Hospital
PitNET2024
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma
First Affiliated Hospital Xi'an Jiaotong University
SSTR PET/CT for Preoperative N Stage Evaluation in GEP-NETs
Peking Union Medical College Hospital
A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors
Qilu Hospital of Shandong University
HETERERO
Charite University, Berlin, Germany
Evaluation of Study Experiences of Neuroendocrine Tumor Patients
Power Life Sciences Inc.
Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine Tumors
Peking University
PPGL-Pred
Rigshospitalet, Denmark
Endoscopic Resection for Small Rectal Neuroendocrine Tumors
Nanfang Hospital, Southern Medical University